| Psoriasis |
1 |
1 |
| Breast |
0 |
0.39 |
| Clinical Research |
0 |
0.39 |
| Gluteal Region |
0 |
0.39 |
| Steroids |
0 |
0.39 |
| Plaque Psoriasis |
0 |
0.99 |
| Pruritus |
0 |
0.26 |
| Healthcare and Medical Technology |
0 |
0.19 |
| Upper Respiratory Tract Infection |
0 |
0.19 |
| Dermatitis |
0 |
0.14 |
| Adolescent Medicine |
0 |
0.98 |
| Adverse Effects |
0 |
0.13 |
| Atopic Dermatitis |
0 |
0.13 |
| Burns |
0 |
0.13 |
| Canada |
0 |
0.13 |
| Grant |
0 |
0.13 |
| Insomnia |
0 |
0.13 |
| Nausea |
0 |
0.13 |
| New York |
0 |
0.13 |
| Otolaryngology |
0 |
0.13 |
| Pain |
0 |
0.13 |
| Respiratory Tract |
0 |
0.13 |
| Sleep |
0 |
0.13 |
| Topical Therapy |
0 |
0.13 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.06 |
| Diarrhea |
0 |
0.06 |
| Headache |
0 |
0.06 |
| Pain Management |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Sleep Disorders |
0 |
0.06 |
| Urinary Tract Infection |
0 |
0.06 |
| Wound Management |
0 |
0.06 |